EUVIMEDEUVIMED entdecken
Crossref

Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series

Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Shinya Yamamoto, Takeshi Matsubara, Sho Masui, Shunsaku Nakagawa, Yasuaki Ikemi, Motoko Yanagita, Manabu Muto, Tomohiro Terada, Atsushi Yonezawa

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04659-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Takashi Masuda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Bevacizumab, Proteinuria, Nivolumab. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabProteinuriaNivolumabHumansMaleFemaleAgedMiddle AgedNeoplasmsAntineoplastic Agents, ImmunologicalCreatinineTandem Mass SpectrometryAged, 80 and overAdultChromatography, Liquid

Stichwörter der Autor:innen

BevacizumabNivolumabPharmacokineticsProteinuria

Substanzen

BevacizumabNivolumabAntineoplastic Agents, ImmunologicalCreatinine

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
  • Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
  • Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Division of Integrative Clinical Pharmacology, Faculty of Pharmacy, Keio University, 1-5-30 Shiba Koen, Minato- ku, Tokyo, 105-8512, Japan.
  • Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Masuda, T., Funakoshi, T., Horimatsu, T., Yamamoto, S., Matsubara, T., Masui, S., Nakagawa, S., Ikemi, Y., Yanagita, M., Muto, M., Terada, T., & Yonezawa, A. (2024). Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04659-3

Vancouver

Masuda T, Funakoshi T, Horimatsu T, Yamamoto S, Matsubara T, Masui S, et al. Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04659-3

BibTeX
@article{Masuda2024,
  author = {Masuda, Takashi and Funakoshi, Taro and Horimatsu, Takahiro and Yamamoto, Shinya and Matsubara, Takeshi and Masui, Sho and Nakagawa, Shunsaku and Ikemi, Yasuaki and Yanagita, Motoko and Muto, Manabu and Terada, Tomohiro and Yonezawa, Atsushi},
  title = {Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04659-3}
}
Kostenlos starten →